HeartSciences Inc.
HSCS | NASDAQ
$5.09
+$0.41 (+8.76%)
Sep 22, 2026, 12:24 PM ET · Market open
Fiscal Year Period Ending | FY 2026 Apr 29, 2026 | FY 2025 Apr 29, 2025 | FY 2024 Apr 29, 2024 | FY 2023 Apr 29, 2023 | FY 2022 Apr 29, 2022 | FY 2021 Apr 29, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | -0.56 | -0.38 | -0.49 | -1.06 | -1.17 | -2.18 |
PEG Ratio | 0.01 | 0.01 | 0.01 | 0.02 | -0.01 | 0.07 |
PS Ratio | 1.19K | 757.08 | 175.12 | 1.3K | 392.55 | 220.02 |
PB Ratio | 0.02 | 16.05 | 0.45 | 29.14 | -0.93 | -2.95 |
P/FCF Ratio | -0.69 | -0.44 | -0.53 | -1.16 | -1.55 | -2.30 |
P/OCF Ratio | -0.69 | -0.44 | -0.54 | -1.16 | -1.55 | -2.30 |
OCF/S Ratio | -171.95K | -170.41K | -32.64K | -112.11K | -25.35K | -9.58K |
Debt / Equity Ratio | 17.46 | 14.55 | 0.14 | 6.79 | -1.02 | -1.61 |
Quick Ratio | 0.40 | 0.41 | 3.84 | 1.10 | 0.36 | 0.80 |
Current Ratio | 0.53 | 0.59 | 4.20 | 1.47 | 0.56 | 1.47 |
Asset Turnover | 0 | 0 | 0 | 0 | 0.01 | 0.01 |
Interest Coverage | -11.17 | -16.69 | -17.81 | -25.14 | -12.67 | -19.39 |
Return on Equity | -4.05% | -4.27K% | -90.27% | -2.76K% | 79.73% | 128.41% |
Return on Assets | -0.17% | -207.56% | -69.51% | -193.30% | -231.08% | -127.23% |
Return on Invested Capital | -0.20% | -261.80% | -75.49% | -308.13% | -1.39K% | -197.33% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | -2.98K% | -2.88K% | -444.16% | -476.91% | -139.73% | -72.93% |
Net Profit Margin | -211.67K% | -201.5K% | -35.51K% | -123.38K% | -33.59K% | -9.58K% |
Pretax Profit Margin | -211.67K% | -201.5K% | -35.51K% | -123.38K% | -33.59K% | -9.58K% |
Operating Profit Margin | -194.79K% | -192.01K% | -33.9K% | -118.7K% | -32.77K% | -10.03K% |
FCF Margin | n/a | -171.11K% | -33.31K% | -112.46K% | -25.37K% | -9.58K% |
EBITDA Margin | -194.79K% | -189.07K% | -33.1K% | -118.14K% | -30.82K% | -8.93K% |
Add to Watchlist
Select watchlists to add or remove HSCS